Clinical Study To Evaluate The Efficacy Of Timirhara Lauha Internally And Dhatyadi Rasakriya Anjana In The Management Of Prathama Patalagata Timira w.s.r Simple Myopia

Not yet recruiting

• Conditions: Myopia. Ayurveda Condition: Pratham Patalagata Timira, (2) ICD-10 Condition: H521||Myopia. Ayurveda Condition: TIMIRAH,

• Registration Number: CTRI/2022/10/046381
• Lead Sponsor: Dr Nalini Yadav

Brief Summary

Myopia is a major public health problem pertaining to eye that entails substantial social, personal ,educational, and economic impacts .Though the modern counterpart has made tremendous progress in the field of ophthalmology but no satisfactory and universally accepted treatment of Myopia is available .Myopia progression is irreversible and there is no cure. Methods of the correction of Myopia are not without complications, including corneal infections due to contact lens wear and corneal scarring and persistent corneal haze from refractive surgery. in Ayurveda texts Timira is said to be " Aushadh sadhya Vyadhi" i.e, medically treatable disease. Various treatment modalities like Snehapana, Sanshodhana, Nasya, Tarpana, Anjana are described in detail. Daily health regimen for healthy eye like Trataka, Padabhayanga, Pranayama, eye exercises are also implemented along with Nidana parivarjana. In the light of above mentioned scenario " DHATRYADI RASAKRIYA ANJANA’ and "TIMIRHAR LAUHA" , has been selected for evaluation of its clinical efficacy in Prathama Patalgata Timira.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-11
• Last Update Posted: 2022-10-10

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• 1. Patients presenting with classical features of Prathama Patalagata Timira.
• 2. Patient Presenting with classical feature of Simple Myopia.
• 3. Patient having refractive error between -0.5D to -6D.

Exclusion Criteria

• 1. Patient having refractive error more than -6D. 2) Patient having other ocular pathology like.
• Cataract, Corneal opacity ,Corneal ulcer. 3) Patient having systematic disorders like Cardio vascular disorder, Diabetes and Hypertension. 4) Contraindicated for Anjana.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in visual acuity of the patient.	6 weeks

Secondary Outcome Measures

Name	Time	Method
Improvement in quality of life.	6 week

Trial Locations

Locations (1)

Govt. Ayurvedic Hospital, erragadda; 🇮🇳 Hyderabad, TELANGANA, India

Govt. Ayurvedic Hospital, erragadda

🇮🇳Hyderabad, TELANGANA, India

Dr Nalini Yadav

Principal investigator

6265269364

naliniyadav60@gmail.com